Characteristics | Group A >70 (n 27) | Group B <70 (n 81) | P value |
---|---|---|---|
mean (± SD) age, years duration of disease, years | 77.5 (±3.1) 14.3 (±8.1) | 29.9 (±10.6) 8.9 (±7.4) | < 0.0001 0.07 |
BMI, mean (± SD) | 20.5 (±3.6) | 21 (±5.7) | 0.22 |
sex, n (M/F) | 12/15 | 32/49 | 0.66 |
use of steroids at time of surgery, n (%) | 13 (48.1) | 31 (38.3) | 0.37 |
use of azathioprine at time of surgery, n (%) | 1 (3.7) | 0 (0) | 0.25 |
use of other-than-anti-UC drugs, n (%) | 16 (59.3) | 31 (38.3) | 0.07 |
comorbidities, n (%) | 24 (88.9) | 21 (17.3) | <0.0001 |
hypoalbuminemia, n (%) | 8 (29.6) | 16 (19.7) | 0.29 |
ASA score ≥ III, n (%) | 9 (33.4) | 5 (6.2) | 0.001 |
3-stage procedure, n (%) | 5 (18.5) | 12 (14.8) | 0.76 |
hand-sewn anastomosis, n (%) | 9 (33.4) | 31 (38.3) | 0.82 |